About the Authors
- Richard Eva
-
Affiliation Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, United Kingdom
- Dalila Bouyoucef-Cherchalli
-
Affiliation The Henry Wellcome Integrated Signalling Laboratories, Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, United Kingdom
- Kalpana Patel
-
Affiliation Department of High-Throughput Biology-Cell Physiology, GlaxoSmithKline, Harlow, United Kingdom
- Peter J. Cullen
-
Affiliation The Henry Wellcome Integrated Signalling Laboratories, Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, United Kingdom
- George Banting
-
* E-mail: g.banting@bristol.ac.uk
Affiliation Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, United Kingdom
Competing Interests
The authors have read the journal's policy and have the following conflicts: Funded in part by a commercial funder (GlaxoSmithKline), who provided part funding for a Ph.D. studentship, which has now been completed. At present, no authors are employed by GlaxoSmithKline, and are not involved with consultancy, patents or products in development or marketed products related to GlaxoSmithKline. The authors are free to adhere to the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: GB PC KP. Performed the experiments: RE DB. Analyzed the data: RE DB GB PC KP. Contributed reagents/materials/analysis tools: GB KP PC. Wrote the paper: RE.